Arbuckle Stuart A

Alnylam Pharmaceuticals Inc · Director

Arbuckle Stuart A is listed in public filings as director. This Arbuckle Stuart A insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Alnylam Pharmaceuticals Inc (ALNY), Praxis Precision Medicines, Inc. (PRAX), Vertex Pharmaceuticals Inc (VRTX), and Rhythm Pharmaceuticals, Inc. (RYTM). Investors use Arbuckle Stuart A's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Alnylam Pharmaceuticals IncALNY$430k1.4k sharesGrant / ExerciseMay 20, 2026$430.1K1.4k shares$298.48--
Alnylam Pharmaceuticals IncALNY--671 sharesGrant / ExerciseMay 20, 2026Disclosure amount unavailable671 shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Praxis Precision Medicines, Inc.PRAX--688 sharesGrant / ExerciseFeb 6, 2026Disclosure amount unavailable688 shares----
Praxis Precision Medicines, Inc.PRAX--1.2k sharesGrant / ExerciseFeb 6, 2026Disclosure amount unavailable478 shares----
Praxis Precision Medicines, Inc.PRAX$72k224 sharesGrant / ExerciseFeb 6, 2026$71.6K224 shares$319.57--
Vertex Pharmaceuticals IncVRTX$29M63.4k sharesGrant / ExerciseJul 1, 2025$16.8M37.2k shares$450.23--
Rhythm Pharmaceuticals, Inc.RYTM$448k7k sharesGrant / ExerciseJun 24, 2025$448.0K7k shares$63.66--
Rhythm Pharmaceuticals, Inc.RYTM--4.7k sharesGrant / ExerciseJun 24, 2025Disclosure amount unavailable4.7k shares----
Rhythm Pharmaceuticals, Inc.RYTM--4k sharesGrant / ExerciseJun 18, 2025Disclosure amount unavailable4k shares----
Vertex Pharmaceuticals IncVRTX--100.6k sharesGrant / ExerciseMay 13, 2025Disclosure amount unavailable37.6k shares----
Vertex Pharmaceuticals IncVRTX$30M62.9k sharesGrant / ExerciseFeb 26, 2025$3.4M7.1k shares$479.61--
Vertex Pharmaceuticals IncVRTX$34M70k sharesGrant / ExerciseFeb 24, 2025$2.3M4.7k shares$483.28--
Vertex Pharmaceuticals IncVRTX$35M74.7k sharesGrant / ExerciseFeb 14, 2025$1.3M2.7k shares$463.46--
Vertex Pharmaceuticals IncVRTX--77.4k sharesGrant / ExerciseFeb 12, 2025Disclosure amount unavailable7.9k shares----